ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Mountain Crest Acquisition Corporation V

Mountain Crest Acquisition Corporation V (MCAG)

11.17
0.00
( 0.00% )
Updated: 09:30:00

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
11.17
Bid
11.10
Ask
11.18
Volume
-
0.00 Day's Range 0.00
10.47 52 Week Range 11.37
Market Cap
Previous Close
11.17
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
2,036
Shares Outstanding
3,170,221
Dividend Yield
-
PE Ratio
-15.73
Earnings Per Share (EPS)
-0.71
Revenue
-
Net Profit
-2.25M

About Mountain Crest Acquisition Corporation V

Mountain Crest Acquisition Corp V is a blank check company. Mountain Crest Acquisition Corp V is a blank check company.

Sector
Blank Checks
Industry
Blank Checks
Headquarters
Wilmington, Delaware, USA
Founded
-
Mountain Crest Acquisition Corporation V is listed in the Blank Checks sector of the NASDAQ with ticker MCAG. The last closing price for Mountain Crest Acquisiti... was $11.17. Over the last year, Mountain Crest Acquisiti... shares have traded in a share price range of $ 10.47 to $ 11.37.

Mountain Crest Acquisiti... currently has 3,170,221 shares outstanding. The market capitalization of Mountain Crest Acquisiti... is $35.41 million. Mountain Crest Acquisiti... has a price to earnings ratio (PE ratio) of -15.73.

MCAG Latest News

Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Makes Progress Towards Regaining Compliance

NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) --  Mountain Crest Acquisition Corp. V (the “Company”) (NASDAQ: MCAG), today announced that it received an expected deficiency notification letter from...

CUBEBIO Announces Business Combination Agreement With Mountain Crest V to Become Publicly Listed

NEW YORK, USA and SEOUL, Korea, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V, a Delaware corporation formed as a special purpose acquisition company (“Mountain Crest V”...

Mountain Crest Acquisition Corp. V Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K and Quarterly Report on Form 10-Q

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (NASDAQ: MCAG, the “Company”) today announced that it received an expected deficiency notification letter from the...

CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V

NEW YORK, USA and SEOUL, Korea, May 02, 2024 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V, a Delaware corporation (“Mountain Crest V”), that is a Nasdaq-listed (Nasdaq: MCAG) special...

Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market

NEW YORK, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) (the “Company”) announced today that it has received approval from the Nasdaq Stock Market...

AUM Biosciences Doses First Patient in Phase 2 Clinical Trial of AUM001 in Metastatic Colorectal Cancer

SINGAPORE and BETHESDA, Md., May 30, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotechnology company focused on discovering and developing precision...

AUM Biosciences to Participate in Inaugural EF Hutton Global Conference

SINGAPORE and BETHESDA, Md., April 26, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotechnology company focused on advancing a pipeline of precision...

AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma

SINGAPORE and BETHESDA, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and developing precision oncology...

AUM Biosciences Receives Human Research Ethics Committee Approval to Commence Phase II Clinical Trial of AUM001 for Treatment of Metastatic Colorectal Cancer in Australia

SINGAPORE and BETHESDA, Md., Nov. 15, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a clinical-stage biotechnology company, advancing a clinical stage candidate and a broader...

AUM Biosciences to Participate in BioCentury-BayHelix East-West BioPharma Summit

SINGAPORE and BETHESDA, Md., Nov. 04, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a clinical-stage biotechnology company, advancing a clinical-stage pipeline of precision...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.030.26929982046711.1411.3411.151111.18098277CS
40.363.3302497687310.8111.3710.81515611.08579323CS
120.171.545454545451111.3710.71203611.04775288CS
260.484.490177736210.6911.3710.47123810.98133304CS
520.54.6860356138710.6711.3710.4779610.91782148CS
156-0.83-6.9166666666712129.6990049.95735869CS
260-0.83-6.9166666666712129.6990049.95735869CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GSIWGarden Stage Ltd
$ 5.16
(127.31%)
49.14M
ZEOZeo Energy Corporation
$ 2.53
(121.93%)
57.71M
TBIOTelesis Bio Inc
$ 2.70
(98.53%)
51.19M
XCURExicure Inc
$ 3.8499
(68.12%)
16.25M
EWTXEdgewise Therapeutics Inc
$ 28.96
(51.86%)
9.56M
HAOHaoxi Health Technology Ltd
$ 0.7596
(-74.68%)
7.12M
HOVRNew Horizon Aircraft Ltd
$ 0.4777
(-35.53%)
2.91M
XCHXCHG Ltd
$ 12.26
(-33.26%)
1.25M
PGNYProgyny Inc
$ 16.48
(-32.57%)
13.49M
BLMZBloomZ Inc
$ 0.955
(-30.29%)
634.93k
NVDANVIDIA Corporation
$ 119.1807
(5.13%)
193.04M
SQQQProShares UltraPro Short QQQ
$ 7.6152
(-9.34%)
164.45M
HOLOMicroCloud Hologram Inc
$ 0.249
(23.08%)
97.55M
MAXNMaxeon Solar Technologies Ltd
$ 0.1008
(10.89%)
92.36M
FRGTFreight Technologies Inc
$ 0.1199
(-3.23%)
79.3M

Discussion

View Full Feed
cjstocksup cjstocksup 2 minutes ago
https://x.com/DC_Draino/status/1836766933389037813
Diamondhands45 Diamondhands45 2 minutes ago
Tired of the action not matching the news. But we shall see soon enough
SPZI
jour_trader jour_trader 2 minutes ago
For my calcs, I’m using a lower flow through of 20%. I expect this to increase with Vyvanse and newer drugs that recently roll to generic.
ELTP
crescentmotor crescentmotor 2 minutes ago
Kudos, george, as your prediction on interest rates are surely propelling stocks forward ... for today, at least.

Yesterday the FED made what amounts to an emergency rate cut of 50 basis points. Not only that, but the FED also make the highly unusual move of signaling cuts of 100 bas
AVXL
Ricorich Ricorich 2 minutes ago
A message from MMG:
$HIRU (our firms opinion) Nay's like clockwork become school yard bullies and come out every Thu & Fri for a feast! First, they mug the new kid on the block for lunch money, then quickly run to principals office (aka OTCM) and complain about the new kid's past activities.
HIRU OTCM
Longer Than Most Longer Than Most 3 minutes ago
This looks nice. .01+ would be bananas and 100% possible
CNNA
Gary Ray Gary Ray 3 minutes ago
In and out swinger

Divy sounds nice but not when they take the trade price
CONY
Filterthenoise Filterthenoise 3 minutes ago
Tik Tok on FOXO & we own it!
FOXO
Double DD Double DD 3 minutes ago
Turtle pace!! Think of a marathon!! Churn baby churn!! Igpk
IGPK
vlispxpert vlispxpert 3 minutes ago
yeaaaah buddy!
Monksdream Monksdream 3 minutes ago
EWTX YTD
https://investorshub.advfn.com/uimage/uploads/2024/9/19/pvixuIMG_1929.gif
EWTX
resx18 resx18 3 minutes ago
Artificial Intelligence Drug Discovery (AIDD) player in the ever-changing world of biotechnology. By leveraging the power of artificial intelligence (AI) to pioneer revolutionary advancements in the industry, Adnexus Biotechnology Inc. is reshaping how new therapies against validated and novel targe
CBDW
Alley-oop Alley-oop 3 minutes ago
https://x.com/alanweedspan/status/1836809243271266787?s=46&t=1dNRSWZkv3NtLyIrK9GGiQ
SMCE
cjstocksup cjstocksup 3 minutes ago
https://x.com/DC_Draino/status/1836832111166378159
lovethatgreen lovethatgreen 3 minutes ago
When sellers stop feeding the 15 bid buyers they will move it into the 16s

The stock is being accumulated and not buy ihub penny players

This is the real deal this time amd they won't be selling in the 20s
RDGL
konshe konshe 4 minutes ago
see close over 0.16 today, tomorrow will be much better.
RDGL
100lbStriper 100lbStriper 4 minutes ago
robcobb $NLST Well we got Judge Gilstrap back on the case for the 293 trial,that is a good thing!We know what we have with him. I really thought Judge Schroeder would have been alright,but Judge Gilstrap knows every little thing that Samsung has done (mostly bad) for the last two years + in all the
NLST
nelson1234 nelson1234 4 minutes ago
nice!
ducci1 ducci1 4 minutes ago
I'll make that my winter project--U hit on it !
SPY
Capsule Capsule 4 minutes ago
- 🎬 **Theaters are a dying breed.** Let's face it—streaming services like Netflix, Disney+, Amazon Prime, and others have fundamentally changed the way people consume entertainment. The days of packed theaters are over. Why would someone spend their hard-earned money on tickets, overpriced s
AMC
cjstocksup cjstocksup 4 minutes ago
https://x.com/DC_Draino/status/1836831399548002685
stock_observer_77 stock_observer_77 4 minutes ago
wow

joined you
prototype_101 prototype_101 4 minutes ago
Comprehensive review LWLG known Customer connections

The Customer Funnel slide was updated at the Safe Capital presentation in April 2024 just a few weeks after the OFC 200Gbs World Class demonstrations, this update showed greater than 20 Prospects and greater than 10 Leads, where in
ASM LWLG TWST
cjstocksup cjstocksup 5 minutes ago
https://x.com/elonmusk/status/1836817314596925739
Stock_Barber Stock_Barber 5 minutes ago
That is a question for Admin.

The baseless-butthurt-money-losing-paranoid-conspiracy-theorist answer is "MANY".

The real answer, as Admin will confirm, is ONE!


https://investorshub.advfn.com/uimage/uploads/2013/9/13/xtkdtBagholder.JPG
DBMM